# A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee

> **NCT01366014** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 157 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** ARRY-371797, p38 inhibitor; oral
- **DRUG:** Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral
- **DRUG:** Placebo; oral

## Key facts

- **NCT ID:** NCT01366014
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01366014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01366014, "A Study of ARRY-371797 in Patients With Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01366014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*